4Poiman CH,Reingold SC,Edan G,et al.Diagnostic Criteria for multiple sclerosis:2005 revisions to the ''McDonald criteria" Ann Neurol,2005,58:840-846. 被引量：1
5Barnes PJ.Molecular mechanisms and cellular effects of glucocorticosteroids.Immunol Allergy clin North Am,2005,25:451-468. 被引量：1
6Lexell EM,Lund ML,Iwarsson S.Constantly changing lives:experiences of people with multiple sclerosis[J].Am J Occup Ther,2009,63(6):772-781. 被引量：1
7Conway D,Cohen JA.Combination therapy in multiple sclerosis[J].Lancet Neurol.2010;9(3):299-308. 被引量：1
8Patti F.Optimizing the benefit of multiple sclerosis therapy:the importance of treatment adherence[J].Patient Prefer Adherence,2010,4:1-9. 被引量：1
9Brajkovi L,Bras M,Milunovi V,et al.The connection between coping mechanisms,depression,anxiety and fatigue in multiple sclerosis[J].Coll Antropol,2009,33 Suppl 2:S135-140. 被引量：1
10Sospedra M,Martin R.Immunology of multiple sclerosis[J].Annu Rev Immanol,2005,23:683. 被引量：1
